Private Prescription: Your Path to Weight Management Choice
Why Private Prescription Makes Wegovy vs Mounjaro Decisions Easier
When evaluating whether Wegovy might be more suitable than Mounjaro for your weight management journey, private prescription removes the barriers that complicate NHS access. Through the NHS route, patients typically face GP referrals to specialist weight management services, followed by waiting lists often exceeding six months before treatment begins. Private prescription streamlines this process, allowing you to access either Wegovy or Mounjaro based on clinical suitability rather than availability constraints.
EverydayMeds offers both medications through our GPhC registered pharmacy (#9012878), ensuring you receive the same genuine products available through NHS channels. The key advantage lies in choice and timing - our prescribers can assess your individual circumstances and recommend the most appropriate option from our complete range of weight management medications, whether that's Wegovy's proven GLP-1 approach or Mounjaro's innovative dual-action mechanism.
Wegovy vs Mounjaro: Transparent Private Prescription Pricing
Understanding the cost implications helps when comparing Wegovy and Mounjaro through private prescription. Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers apply code FIRST40 at checkout, whilst returning patients use DOSE25 to access these prices. Our bundle options include the Intro Trio (0.25mg, 0.5mg, 1mg) at £299.99, providing three months of step-up dosing in a single order.
Mounjaro pricing follows its own structure, reflecting the different dosing schedule and manufacturer pricing. Both medications represent a significant investment in your health, but private prescription eliminates the uncertainty of NHS availability and provides assured access to your chosen treatment. The convenience of home delivery, clinical support, and flexible ordering through bundles like our Ultimate Stability Trio (three 2.4mg pens for £649.99) often justifies the private route for patients seeking consistent, uninterrupted treatment.
Clinical Evidence: Wegovy and Mounjaro Trial Data Comparison
When considering whether Wegovy offers advantages over Mounjaro, clinical trial evidence provides valuable insights without direct head-to-head comparisons. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks in STEP 1, with sustained results of 15.2% at two years in STEP 5. The recent SELECT trial also demonstrated a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
Mounjaro's SURMOUNT trials showed impressive results with its dual GIP/GLP-1 receptor agonist mechanism, though direct percentage comparisons aren't appropriate due to different trial designs and patient populations. Both medications require prescription-only access and work alongside reduced-calorie diets and increased physical activity to achieve optimal results, as referenced in the foundational research by Wilding et al., published in the New England Journal of Medicine, 2021.
How Wegovy Works vs Mounjaro's Dual Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone GLP-1 to reduce appetite and promote feelings of fullness after smaller meals. This mechanism may help reduce food cravings by acting on brain appetite centres, supporting patients in maintaining caloric reduction more comfortably. Mounjaro (tirzepatide) combines GLP-1 activity with GIP receptor agonism, creating a dual-hormone approach that may offer different benefits for some patients. Both medications slow gastric emptying and enhance insulin sensitivity when glucose levels are elevated, but their distinct mechanisms may suit different patient profiles. Your prescriber can help determine which approach aligns better with your medical history and weight management goals.
Streamlined Private Prescription Ordering Process
Accessing either Wegovy or Mounjaro through EverydayMeds begins with our three-minute online clinical assessment, covering medical history, current medications, and weight management goals. Our qualified prescribers review applications within three working days (or 24 hours with express service), ensuring appropriate medication selection based on clinical suitability rather than formulary restrictions. Once approved, we dispatch your medication via next-day delivery using temperature-controlled cold-chain logistics to maintain medication integrity from our pharmacy to your door. The process eliminates GP appointments, specialist referrals, and waiting room delays whilst maintaining full clinical oversight and safety standards. Payment is secure, pricing is transparent, and ongoing support is available throughout your treatment journey.
Storage and Practical Considerations: Wegovy vs Mounjaro
Practical differences between Wegovy and Mounjaro may influence your choice, particularly regarding storage and travel convenience. Wegovy can remain at room temperature (below 30°C) for up to six weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit, making Wegovy more suitable for extended travel or irregular refrigeration access. Both medications use pre-filled injection pens, but Wegovy's FlexTouch system and Mounjaro's pen design offer slightly different user experiences. The dose escalation schedules differ too - Wegovy progresses through five dose levels over 16 weeks to reach maintenance, whilst Mounjaro follows its own titration schedule. Storage requirements are similar (2-8°C refrigeration), but Wegovy's extended room temperature stability provides additional flexibility for busy lifestyles.
Private Access Advantages for Wegovy vs Mounjaro Selection
Private prescription uniquely positions patients to make informed choices between Wegovy and Mounjaro based on clinical suitability rather than availability constraints. NHS formularies and local prescribing guidelines may limit which medication is offered first, potentially delaying access to the most appropriate option for your circumstances. Through private prescription, both medications are equally available, allowing prescribers to recommend based purely on clinical factors such as your medical history, previous treatment responses, and lifestyle considerations.
This flexibility proves particularly valuable for patients who may benefit from switching between medications or those with specific requirements around dosing schedules, storage needs, or injection frequency preferences. EverydayMeds maintains stock of both medications, ensuring consistent supply chains that aren't subject to NHS shortages or regional availability issues that sometimes affect public healthcare access to these prescription-only medicines.
Making Your Choice: Expert Guidance and Ongoing Support
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which is right for you based on your individual clinical profile. Our transparent pricing, with codes FIRST40 for new customers and DOSE25 for returning patients, ensures you understand costs upfront without hidden fees or subscription commitments. The convenience of private prescription, combined with clinical expertise from our GPhC registered pharmacy (#9012878), provides the support framework necessary for successful long-term weight management. Whether you choose Wegovy's established GLP-1 approach or Mounjaro's dual-action mechanism, private prescription offers the speed, choice, and continuity that supports sustainable results. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment today, with next-day delivery available once your prescription is approved by our qualified prescribers.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
